Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
AstraZeneca
Dow
Julphar
Express Scripts
Baxter
Moodys
Cerilliant
Queensland Health
McKinsey

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,911,851

« Back to Dashboard

Summary for Patent: 5,911,851
Title: Atomizing nozzle and filter and spray generating device
Abstract:A nozzle assembly for use in atomizing and generating sprays from a fluid. The nozzle assembly includes two members joined together. In one of the two members are formed one or more nozzle outlets, one or more fluid inlets, and a plurality of channels that form filter passageways. The nozzle outlets discharge fluid jets that impinge on one another to thereby atomize the fluid. Alternatively, an impact element or a vortex-generating structure can be used in the nozzle outlet to atomize the fluid. Methods are also provided for producing the nozzle assembly by forming the inlets, outlets, and/or channels through electrical or chemical etching or other processes that selectively remove material from at least one face of a nozzle assembly member.
Inventor(s): Bartels; Frank (Waldbronn, DE), Bachtler; Wulf (Mainz, DE), Dunne; Stephen Terence (Suffolk, GB), Eicher; Joachim (Karlsruhe, DE), Freund; Bernhard (Gau-Algesheim, DE), Hart; William Barrie (Suffolk, GB), Lessmoellmann; Christoph (Gernsbach, DE)
Assignee: Boehringer Ingelheim International GmbH (DE)
Application Number:08/661,741
Patent Claim Types:
see list of patent claims
Device;

Drugs Protected by US Patent 5,911,851

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,911,851

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9220505Sep 29, 1992
Germany4236037Oct 24, 1992
United Kingdom9314804Jul 19, 1993

International Patents Family Members for US Patent 5,911,851

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 183673 ➤ Sign Up
Austria 312669 ➤ Sign Up
Austria 421384 ➤ Sign Up
Australia 4829993 ➤ Sign Up
Canada 2145758 ➤ Sign Up
Canada 2445256 ➤ Sign Up
Canada 2475424 ➤ Sign Up
China 1087843 ➤ Sign Up
China 1093006 ➤ Sign Up
China 1342524 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Queensland Health
Fuji
Cantor Fitzgerald
Covington
Johnson and Johnson
Teva
Healthtrust
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot